Tim Petersen
Managing Director

Tim Petersen joined Arboretum Ventures as a Managing Director in 2002.

Tim’s investment focus has been shaped by his broad business experience with creating, growing, and financing entrepreneurial firms. His investments target capital-efficient companies in medical technology, health IT and services that redefine efficient models for care delivery and improve access to care. Tim has led investments and held board seats in more than a dozen portfolio companies during his tenure with Arboretum. Exited investments include Accuri, HealthMedia, Inogen (Nasdaq: INGN) and IntelliCyt, each generating between four and ten times Arboretum’s investment. Inogen, which went public in 2014, currently has a market capitalization in excess of $1 billion.

From 1999 to 2002, he helped establish the Zell Lurie Institute for Entrepreneurial Studies at the University of Michigan, serving as its Managing Director. The Institute has been consistently ranked as one of the top three entrepreneurship programs in the country. During his tenure at Michigan, he also directed the activities of the Wolverine Venture Fund, the Institute’s venture capital fund focusing on early-stage life science and technology investments. Prior to Michigan, Tim was a manager in the investment banking practice at Plante Moran Corporate Finance and served as a management consultant at Industrial Economics, Inc. in Cambridge, MA.

Profile PDFHigh-res Image

Current Board Seats
Advanced ICU Care
Concerto Health
KFx Medical
Pear Therapeutics
Previous Portfolio Involvement
Accuri Cytometers (acquired)
HealthMedia (acquired)
Inogen [Nasdaq: INGN]
IntelliCyt (acquired)
BA in Economics, Williams College
MS in Economics, University of Wisconsin-Madison
MBA, Ross School of Business, University of Michigan
Activities & Affiliations
Chairman, Michigan Venture Capital Association
Alumni Fund Manager, Wolverine Venture Fund, Ross Business School
Assistant: Amanda Goldstein
Loading posts...